What a 41% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 39 of 48 of this archive, newest first.
Follow the resin, not the catalogue.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.
The supplier has not disputed the finding. It has not explained the gap either.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
A reminder that a purity figure is the output of a method, and that methods differ.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Follow the resin, not the catalogue.